Review
BibTex RIS Cite

The Power of Herbal Extracts and Essential Oils in the Fight Against Helicobacter pylori: A Current Review

Year 2025, Volume: 9 Issue: 2, 84 - 94, 24.12.2025

Selin Sipahi Kuloğlu , Tuğçe Kalefetoğlu Macar , Oksal Macar

https://doi.org/10.29002/asujse.1799861

Abstract

Helicobacter pylori is a human pathogen bacterium that causes gastric and duodenal diseases. This bacterium, which infects approximately half of the global population, is classified as a Group I carcinogen. Diseases caused by this bacterium, which can lead to very serious conditions ranging from gastritis to stomach cancer, can develop due to iron deficiency anemia or B12 vitamin deficiency. The presence of this bacterium in the saliva, feces, and vomit of infected individuals indicates the possibility of transmission through these routes. Due to the emergence of antibiotic-resistant strains of H. pylori, there is a need for natural complementary treatments. The side effects of drugs have led researchers to turn to nature, and plant-based functional foods have gained importance. It is well recognized that active ingredients frequently present in plant extracts are crucial in the treatment of H. pylori. It is very valuable for literature to draw attention to these alternative treatments and make them available.

Keywords

antibacterial activity cancer herbal oil Helicobacter pylori

References

  • [1] Reshetnyak, V. I., Reshetnyak, T. M. (2017). Significance of dormant forms of Helicobacter pylori in ulcerogenesis. World J Gastroenterol, 23(27), 4867-4878. https://doi.org/10.3748/wjg.v23.i27.4867
  • [2] Kusters, J. G., Van Vliet, A. H., & Kuipers, E. J. (2006). Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 19(3), 449-490. https://doi.org/10.1128/cmr.00054-05
  • [3] Malfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R et al. (2023). Helicobacter pylori infection. Nat Rev Dis Primers. 9(1), 19. https://doi.org/10.1038/s41572-023-00431-8
  • [4] Gürbüz, E. D., Yılmaz, Ö. (2011). Helicobacter pylori'nin Yaşam Stratejisi. Türk Mikrobiyoloji Cemiyeti Dergisi, 41(2), 49-56. https://doi.org/10.5222/TMCD.2011.049
  • [5] Schreiber, S., Konradt, M., Groll, C., Scheid, P., Hanauer, G et al. (2004). The spatial orientation of Helicobacter pylori in the gastric mucus. PNAS. 101(14), 5024-5029. https://doi.org/10.1073/pnas.0308386101
  • [6] Kirschner, D. E., Blaser, M. J. (1995). The dynamics of Helicobacter pylori infection of the human stomach. J Theor Biol. 176(2), 281-290. https://doi.org/10.1006/jtbi.1995.0198
  • [7] Cover, T. L., Blanke, S. R. (2005). Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol. 3(4), 320-332. https://doi.org/10.1038/nrmicro1095
  • [8] Sathianarayanan, S., Ammanath, A. V., Biswas, R., Sukumaran, S., Venkidasamy, B. (2022). A new approach against Helicobacter pylori using plants and its constituents: A review study. Microb Pathog. 168, 105594. https://doi.org/10.1016/j.micpath.2022.105594
  • [9] Tabak, M., Armon, R., & Neeman, I. (1999). Cinnamon extracts’ inhibitory effect on Helicobacter pylori. J. Ethnopharmacol. 67(3), 269-277. https://doi.org/10.1016/S0378-8741(99)00054-9
  • [10] Korona-Glowniak, I., Glowniak-Lipa, A., Ludwiczuk, A., Baj, T., & Malm, A. (2020). The in vitro activity of essential oils against Helicobacter pylori growth and urease activity. Molecules, 25(3), 586. https://doi.org/10.3390/molecules25030586
  • [11] Cui, M., Ji, X., Guan, F., Su, G., & Du, L. (2024). Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics. Frontiers in immunology, 15, 1432968. https://doi.org/10.3389/fimmu.2024.1432968
  • [12] Bordin, D. S., Voynovan, I. N., Andreev, D. N., Maev, I. V. (2021). Current Helicobacter pylori diagnostics. Diagnostics, 11(8), 1458. https://doi.org/10.3390/diagnostics11081458
  • [13] Álvarez-Arellano, L., Maldonado-Bernal, C. (2014). Helicobacter pylori and neurological diseases: Married by the laws of inflammation. World J Gastrointest Pathophysiol. 5(4), 400. https://doi.org/10.4291/wjgp.v5.i4.400
  • [14] Sipponen, P. (1997). Helicobacter pylori gastritis—epidemiology. J Gastroenterol. 32(2), 273-277. https://doi.org/10.1007/BF02936382
  • [15] Moss, S. F. (2017). The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol. 3(2), 183-191. https://doi.org/10.1016/j.jcmgh.2016.12.001
  • [16] de Martel, C., Georges, D., Bray, F., Ferlay, J., Clifford, G. M. (2020). Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 8(2), e180-e190. https://doi.org/10.1016/S2214-109X(19)30488-7
  • [17] Arnold, M., Moore, S. P., Hassler, S., Ellison-Loschmann, L., Forman, D et al. (2014). The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut, 63(1), 64-71. https://doi.org/10.1136/gutjnl-2013-305033
  • [18] Gülseroğlu, S., Yılmaz, N., Tekin, D., Özamrak, B. G., Talu, E. C. K. (2023). Dışkı Örneklerinde Helicobacter pylori Antijen Testi Pozitifliği olan Hastaların Patoloji Bulguları ile Beraber Retrospektif Olarak Değerlendirilmesi. Ağrı Tıp Fakültesi Dergisi, 1(2), 26-29. https://dergipark.org.tr/tr/pub/agrimedical/article/1264062#article_cite
  • [19] Zamani, M., Ebrahimtabar, F., Zamani, V., Miller, W., Alizadeh‐Navaei, R et al. (2018). Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection. AP&T. 47(7), 868-876. https://doi.org/10.1111/apt.14561
  • [20] Liu, M., Gao, H., Miao, J., Zhang, Z., Zheng, L et al. (2024). Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review. Front Microbiol. 14, 1330029. https://doi.org/10.3389/fmicb.2023.1330029
  • [21] Khoder, G., Muhammad, J. S., Mahmoud, I., Soliman, S. S., Burucoa, C. (2019). Prevalence of Helicobacter pylori and its associated factors among healthy asymptomatic residents in the United Arab Emirates. Pathogens, 8(2), 44. https://doi.org/10.3390/pathogens8020044
  • [22] Stefano, K., Marco, M., Federica, G., Laura, B., Barbara, B et al. (2018). Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Bio Medica: Atenei Parmensis, 89(Suppl 8), 72. https://doi.org/10.23750/abm.v89i8-S.7947
  • [23] Fock, K. M., Ang, T. L. (2010). Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol. 25(3), 479-486. https://doi.org/10.1111/j.1440-1746.2009.06188.x
  • [24] Ren, S., Cai, P., Liu, Y., Wang, T., Zhang, Y et al. (2022). Prevalence of Helicobacter pylori infection in China: A systematic review and meta‐analysis. J Gastroenterol Hepatol. 37(3), 464-470. https://doi.org/10.1111/jgh.15751
  • [25] Thorell, K., Muñoz-Ramírez, Z. Y., Wang, D., Sandoval-Motta, S., Boscolo Agostini, R et al. (2023). The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes. Nat Commun. 14(1), 8184. https://doi.org/10.1038/s41467-023-43562-y
  • [26] Herrero, R., Park, J. Y., Forman, D. (2014). The fight against gastric cancer–the IARC Working Group report. Best Pract. Res. Clin. Gastroenterol. 28(6), 1107-1114. https://doi.org/10.1016/j.bpg.2014.10.003
  • [27] Safavi, M., Shams-Ardakani, M., Foroumadi, A. (2015). Medicinal plants in the treatment of Helicobacter pylori infections. Pharm Biol.53(7), 939-960. https://doi.org/10.3109/13880209.2014.952837
  • [28] Pichon, M., Pichard, B., Barrioz, T., Plouzeau, C., Croquet, V et al. (2020). Diagnostic accuracy of a noninvasive test for detection of Helicobacter pylori and resistance to clarithromycin in stool by the Amplidiag H. pylori+ ClariR real-time PCR assay. J Clin Microbiol. 58(4), 10.1128/jcm. 01787-01719. https://doi.org/10.1128/jcm.01787-19
  • [29] Silvan, J. M., Gutiérrez-Docio, A., Moreno-Fernandez, S., Alarcón-Cavero, T., Prodanov, M et al. (2020). Procyanidin-rich extract from grape seeds as a putative tool against Helicobacter pylori. Foods, 9(10), 1370. https://doi.org/10.3390/foods9101370
  • [30] Garvey, E., Rhead, J., Suffian, S., Whiley, D., Mahmood, F et al. (2023). High incidence of antibiotic resistance amongst isolates of Helicobacter pylori collected in Nottingham, UK, between 2001 and 2018. J Med Microbiol. 72(11), 001776. https://doi.org/10.1099/jmm.0.001776
  • [31] Poonyam, P., Chotivitayatarakorn, P., Vilaichone, R.-K. (2019). High effective of 14-day high-dose PPI-bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradication: a double blinded-randomized placebo-controlled study. APJCP, 20(9), 2859. https://doi.org/10.31557/APJCP.2019.20.9.2859
  • [32] Chey, W. D., Howden, C. W., Moss, S. F., Morgan, D. R., Greer, K. B., Grover, S., & Shah, S. C. (2024). ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol, 119(9), 1730-1753. http://doi.org/10.14309/ajg.0000000000002968
  • [33] Wu, P.-J., Tsay, F.-W., Wu, D.-C., Yang, J.-C., Chuah, S.-K., Chen, K.-Y., Sheu, M.-J. (2025). Sequential changes of antibiotic resistances of Helicobacter pylori in Taiwan from 2019 to 2024. World J Gastroenterol, 31(39), 111380. http://doi.org/10.3748/wjg.v31.i39.111380
  • [34] Zhou, X.-Z., Lyu, N.-H., Zhu, H.-Y., Cai, Q.-C., Kong, X.-Y., Xie, P., Du, Y.-Q. (2023). Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention. Gut, 72(5), 855-869.
  • [35] Silvan, J. M., Gutiérrez-Docio, A., Moreno-Fernandez, S., Alarcón-Cavero, T., Prodanov, M et al. (2020). Procyanidin-rich extract from grape seeds as a putative tool against Helicobacter pylori. Foods, 9(10), 1370. https://doi.org/10.3390/foods9101370
  • [36] Nostro, A., Cellini, L., Bartolomeo, S. D., Cannatelli, M., Campli, E. D et al. (2006). Effects of combining extracts (from propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 20(3), 187-190. https://doi.org/10.1002/ptr.1830
  • [37] Wang, Y.-C. (2014). Medicinal plant activity on Helicobacter pylori related diseases. WJG. 20(30), 10368. https://doi.org/10.3748/wjg.v20.i30.10368
  • [38] Abou Baker, D. (2020). Plants against Helicobacter pylori to combat resistance: An ethnopharmacological review. Biotechnol Rep. 26, e00470. https://doi.org/10.1016/j.btre.2020.e00470
  • [39] Hajimahmoodi, M., Shams-Ardakani, M., Saniee, P., Siavoshi, F., Mehrabani, M et al. (2011). In vitro antibacterial activity of some Iranian medicinal plant extracts against Helicobacter pylori. Nat Prod Res. 25(11), 1059-1066. https://doi.org/10.1080/14786419.2010.501763
  • [40] Nostro, A., Cellini, L., Bartolomeo, S. D., Campli, E. D., Grande, R et al. (2005). Antibacterial effect of plant extracts against Helicobacter pylori. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 19(3), 198-202. https://doi.org/10.1002/ptr.1640
  • [41] Cogo, L. L., Monteiro, C. L. B., Miguel, M. D., Miguel, O. G., Cunico, M. M et al. (2010). Anti-Helicobacter pylori activity of plant extracts traditionally used for the treatment of gastrointestinal disorders. Braz J Microbiol. 41, 304-309. https://doi.org/10.1590/S1517-83822010000200007
  • [42] Nariman, F., Eftekhar, F., Habibi, Z., Falsafi, T. (2004). Anti‐Helicobacter pylori activities of six Iranian plants. Helicobacter, 9(2), 146-151. https://doi.org/10.1111/j.1083-4389.2004.00211.x
  • [43] Ndip, R. N., Tarkang, A. E. M., Mbullah, S. M., Luma, H. N., Malongue, A et al. (2007). In vitro anti-Helicobacter pylori activity of extracts of selected medicinal plants from North West Cameroon. J Ethnopharmacol. 114(3), 452-457. https://doi.org/10.1016/j.jep.2007.08.037
  • [44] Yan, J., Peng, C., Chen, P., Zhang, W., Jiang, C et al. (2022). In-vitro anti-Helicobacter pylori activity and preliminary mechanism of action of Canarium album Raeusch. fruit extracts. J Ethnopharmacol. 283, 114578. https://doi.org/10.1016/j.jep.2021.114578
  • [45] Gao, T., Hou, M., Zhang, B., Pan, X., Liu, C., Sun, C., ... & Ma, A. (2021). Effects of cranberry beverages on oxidative stress and gut microbiota in subjects with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial. Food Funct. 12(15), 6878-6888. https://doi.org/10.1039/D1FO00467K
  • [46] Chen, S., Shen, W., Liu, Y., Dong, Q., & Shi, Y. (2023). Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial. Chin Med J, 136(14), 1690-1698. https://mednexus.org/doi/epdf/10.1097/CM9.0000000000002696
  • [47] Edo, G. I., Obasohan, P., Makia, R. S., Abiola O, T., Umelo, E. C., Jikah, A. N., Umar, H. (2024). The use of quality control parameters in the evaluation of herbal drugs. A review. Discover Medicine, 1(1), 168. http://doi.org/10.1007/s44337-024-00177-6
  • [48] Wang, H., Chen, Y., Wang, L., Liu, Q., Yang, S., & Wang, C. (2023). Advancing herbal medicine: enhancing product quality and safety through robust quality control practices. Front Pharmacol, 14, 1265178. http://doi.org/10.3389/fphar.2023.1265178

Helicobacter pylori ile Mücadelede Bitki Özleri ve Uçucu Yağların Gücü: Güncel Bir İnceleme

Year 2025, Volume: 9 Issue: 2, 84 - 94, 24.12.2025

Selin Sipahi Kuloğlu , Tuğçe Kalefetoğlu Macar , Oksal Macar

https://doi.org/10.29002/asujse.1799861

Abstract

Helicobacter pylori, mide ve oniki parmak bağırsağı hastalıklarına neden olan bir insan patojeni bakteridir. Küresel nüfusun yaklaşık yarısını enfekte eden bu bakteri, Grup I kanserojen olarak sınıflandırılmaktadır. Gastritten mide kanserine kadar çok ciddi durumlara yol açabilen bu bakterinin neden olduğu hastalıklar, demir eksikliği anemisi veya B12 vitamini eksikliği nedeniyle gelişebilir. Bu bakterinin enfekte bireylerin tükürüğünde, dışkısında ve kusmuğunda bulunması, bu yollardan bulaşma olasılığını gösterir. Antibiyotik dirençli H. pylori suşlarının ortaya çıkması nedeniyle, doğal tamamlayıcı tedavilere ihtiyaç vardır. İlaçların yan etkileri, araştırmacıları doğaya yöneltmiş ve bitki bazlı fonksiyonel gıdalar önem kazanmıştır. Bitki özlerinde sıklıkla bulunan aktif bileşenlerin H. pylori tedavisinde çok önemli olduğu iyi bilinmektedir. Literatürün bu alternatif tedavilere dikkat çekmesi ve bunları erişilebilir hale getirmesi çok değerlidir.

Keywords

Antibakteriyel aktivite kanser bitki yağları Helicobacter pylori

References

  • [1] Reshetnyak, V. I., Reshetnyak, T. M. (2017). Significance of dormant forms of Helicobacter pylori in ulcerogenesis. World J Gastroenterol, 23(27), 4867-4878. https://doi.org/10.3748/wjg.v23.i27.4867
  • [2] Kusters, J. G., Van Vliet, A. H., & Kuipers, E. J. (2006). Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 19(3), 449-490. https://doi.org/10.1128/cmr.00054-05
  • [3] Malfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R et al. (2023). Helicobacter pylori infection. Nat Rev Dis Primers. 9(1), 19. https://doi.org/10.1038/s41572-023-00431-8
  • [4] Gürbüz, E. D., Yılmaz, Ö. (2011). Helicobacter pylori'nin Yaşam Stratejisi. Türk Mikrobiyoloji Cemiyeti Dergisi, 41(2), 49-56. https://doi.org/10.5222/TMCD.2011.049
  • [5] Schreiber, S., Konradt, M., Groll, C., Scheid, P., Hanauer, G et al. (2004). The spatial orientation of Helicobacter pylori in the gastric mucus. PNAS. 101(14), 5024-5029. https://doi.org/10.1073/pnas.0308386101
  • [6] Kirschner, D. E., Blaser, M. J. (1995). The dynamics of Helicobacter pylori infection of the human stomach. J Theor Biol. 176(2), 281-290. https://doi.org/10.1006/jtbi.1995.0198
  • [7] Cover, T. L., Blanke, S. R. (2005). Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol. 3(4), 320-332. https://doi.org/10.1038/nrmicro1095
  • [8] Sathianarayanan, S., Ammanath, A. V., Biswas, R., Sukumaran, S., Venkidasamy, B. (2022). A new approach against Helicobacter pylori using plants and its constituents: A review study. Microb Pathog. 168, 105594. https://doi.org/10.1016/j.micpath.2022.105594
  • [9] Tabak, M., Armon, R., & Neeman, I. (1999). Cinnamon extracts’ inhibitory effect on Helicobacter pylori. J. Ethnopharmacol. 67(3), 269-277. https://doi.org/10.1016/S0378-8741(99)00054-9
  • [10] Korona-Glowniak, I., Glowniak-Lipa, A., Ludwiczuk, A., Baj, T., & Malm, A. (2020). The in vitro activity of essential oils against Helicobacter pylori growth and urease activity. Molecules, 25(3), 586. https://doi.org/10.3390/molecules25030586
  • [11] Cui, M., Ji, X., Guan, F., Su, G., & Du, L. (2024). Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics. Frontiers in immunology, 15, 1432968. https://doi.org/10.3389/fimmu.2024.1432968
  • [12] Bordin, D. S., Voynovan, I. N., Andreev, D. N., Maev, I. V. (2021). Current Helicobacter pylori diagnostics. Diagnostics, 11(8), 1458. https://doi.org/10.3390/diagnostics11081458
  • [13] Álvarez-Arellano, L., Maldonado-Bernal, C. (2014). Helicobacter pylori and neurological diseases: Married by the laws of inflammation. World J Gastrointest Pathophysiol. 5(4), 400. https://doi.org/10.4291/wjgp.v5.i4.400
  • [14] Sipponen, P. (1997). Helicobacter pylori gastritis—epidemiology. J Gastroenterol. 32(2), 273-277. https://doi.org/10.1007/BF02936382
  • [15] Moss, S. F. (2017). The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol. 3(2), 183-191. https://doi.org/10.1016/j.jcmgh.2016.12.001
  • [16] de Martel, C., Georges, D., Bray, F., Ferlay, J., Clifford, G. M. (2020). Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 8(2), e180-e190. https://doi.org/10.1016/S2214-109X(19)30488-7
  • [17] Arnold, M., Moore, S. P., Hassler, S., Ellison-Loschmann, L., Forman, D et al. (2014). The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut, 63(1), 64-71. https://doi.org/10.1136/gutjnl-2013-305033
  • [18] Gülseroğlu, S., Yılmaz, N., Tekin, D., Özamrak, B. G., Talu, E. C. K. (2023). Dışkı Örneklerinde Helicobacter pylori Antijen Testi Pozitifliği olan Hastaların Patoloji Bulguları ile Beraber Retrospektif Olarak Değerlendirilmesi. Ağrı Tıp Fakültesi Dergisi, 1(2), 26-29. https://dergipark.org.tr/tr/pub/agrimedical/article/1264062#article_cite
  • [19] Zamani, M., Ebrahimtabar, F., Zamani, V., Miller, W., Alizadeh‐Navaei, R et al. (2018). Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection. AP&T. 47(7), 868-876. https://doi.org/10.1111/apt.14561
  • [20] Liu, M., Gao, H., Miao, J., Zhang, Z., Zheng, L et al. (2024). Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review. Front Microbiol. 14, 1330029. https://doi.org/10.3389/fmicb.2023.1330029
  • [21] Khoder, G., Muhammad, J. S., Mahmoud, I., Soliman, S. S., Burucoa, C. (2019). Prevalence of Helicobacter pylori and its associated factors among healthy asymptomatic residents in the United Arab Emirates. Pathogens, 8(2), 44. https://doi.org/10.3390/pathogens8020044
  • [22] Stefano, K., Marco, M., Federica, G., Laura, B., Barbara, B et al. (2018). Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Bio Medica: Atenei Parmensis, 89(Suppl 8), 72. https://doi.org/10.23750/abm.v89i8-S.7947
  • [23] Fock, K. M., Ang, T. L. (2010). Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol. 25(3), 479-486. https://doi.org/10.1111/j.1440-1746.2009.06188.x
  • [24] Ren, S., Cai, P., Liu, Y., Wang, T., Zhang, Y et al. (2022). Prevalence of Helicobacter pylori infection in China: A systematic review and meta‐analysis. J Gastroenterol Hepatol. 37(3), 464-470. https://doi.org/10.1111/jgh.15751
  • [25] Thorell, K., Muñoz-Ramírez, Z. Y., Wang, D., Sandoval-Motta, S., Boscolo Agostini, R et al. (2023). The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes. Nat Commun. 14(1), 8184. https://doi.org/10.1038/s41467-023-43562-y
  • [26] Herrero, R., Park, J. Y., Forman, D. (2014). The fight against gastric cancer–the IARC Working Group report. Best Pract. Res. Clin. Gastroenterol. 28(6), 1107-1114. https://doi.org/10.1016/j.bpg.2014.10.003
  • [27] Safavi, M., Shams-Ardakani, M., Foroumadi, A. (2015). Medicinal plants in the treatment of Helicobacter pylori infections. Pharm Biol.53(7), 939-960. https://doi.org/10.3109/13880209.2014.952837
  • [28] Pichon, M., Pichard, B., Barrioz, T., Plouzeau, C., Croquet, V et al. (2020). Diagnostic accuracy of a noninvasive test for detection of Helicobacter pylori and resistance to clarithromycin in stool by the Amplidiag H. pylori+ ClariR real-time PCR assay. J Clin Microbiol. 58(4), 10.1128/jcm. 01787-01719. https://doi.org/10.1128/jcm.01787-19
  • [29] Silvan, J. M., Gutiérrez-Docio, A., Moreno-Fernandez, S., Alarcón-Cavero, T., Prodanov, M et al. (2020). Procyanidin-rich extract from grape seeds as a putative tool against Helicobacter pylori. Foods, 9(10), 1370. https://doi.org/10.3390/foods9101370
  • [30] Garvey, E., Rhead, J., Suffian, S., Whiley, D., Mahmood, F et al. (2023). High incidence of antibiotic resistance amongst isolates of Helicobacter pylori collected in Nottingham, UK, between 2001 and 2018. J Med Microbiol. 72(11), 001776. https://doi.org/10.1099/jmm.0.001776
  • [31] Poonyam, P., Chotivitayatarakorn, P., Vilaichone, R.-K. (2019). High effective of 14-day high-dose PPI-bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradication: a double blinded-randomized placebo-controlled study. APJCP, 20(9), 2859. https://doi.org/10.31557/APJCP.2019.20.9.2859
  • [32] Chey, W. D., Howden, C. W., Moss, S. F., Morgan, D. R., Greer, K. B., Grover, S., & Shah, S. C. (2024). ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol, 119(9), 1730-1753. http://doi.org/10.14309/ajg.0000000000002968
  • [33] Wu, P.-J., Tsay, F.-W., Wu, D.-C., Yang, J.-C., Chuah, S.-K., Chen, K.-Y., Sheu, M.-J. (2025). Sequential changes of antibiotic resistances of Helicobacter pylori in Taiwan from 2019 to 2024. World J Gastroenterol, 31(39), 111380. http://doi.org/10.3748/wjg.v31.i39.111380
  • [34] Zhou, X.-Z., Lyu, N.-H., Zhu, H.-Y., Cai, Q.-C., Kong, X.-Y., Xie, P., Du, Y.-Q. (2023). Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention. Gut, 72(5), 855-869.
  • [35] Silvan, J. M., Gutiérrez-Docio, A., Moreno-Fernandez, S., Alarcón-Cavero, T., Prodanov, M et al. (2020). Procyanidin-rich extract from grape seeds as a putative tool against Helicobacter pylori. Foods, 9(10), 1370. https://doi.org/10.3390/foods9101370
  • [36] Nostro, A., Cellini, L., Bartolomeo, S. D., Cannatelli, M., Campli, E. D et al. (2006). Effects of combining extracts (from propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 20(3), 187-190. https://doi.org/10.1002/ptr.1830
  • [37] Wang, Y.-C. (2014). Medicinal plant activity on Helicobacter pylori related diseases. WJG. 20(30), 10368. https://doi.org/10.3748/wjg.v20.i30.10368
  • [38] Abou Baker, D. (2020). Plants against Helicobacter pylori to combat resistance: An ethnopharmacological review. Biotechnol Rep. 26, e00470. https://doi.org/10.1016/j.btre.2020.e00470
  • [39] Hajimahmoodi, M., Shams-Ardakani, M., Saniee, P., Siavoshi, F., Mehrabani, M et al. (2011). In vitro antibacterial activity of some Iranian medicinal plant extracts against Helicobacter pylori. Nat Prod Res. 25(11), 1059-1066. https://doi.org/10.1080/14786419.2010.501763
  • [40] Nostro, A., Cellini, L., Bartolomeo, S. D., Campli, E. D., Grande, R et al. (2005). Antibacterial effect of plant extracts against Helicobacter pylori. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 19(3), 198-202. https://doi.org/10.1002/ptr.1640
  • [41] Cogo, L. L., Monteiro, C. L. B., Miguel, M. D., Miguel, O. G., Cunico, M. M et al. (2010). Anti-Helicobacter pylori activity of plant extracts traditionally used for the treatment of gastrointestinal disorders. Braz J Microbiol. 41, 304-309. https://doi.org/10.1590/S1517-83822010000200007
  • [42] Nariman, F., Eftekhar, F., Habibi, Z., Falsafi, T. (2004). Anti‐Helicobacter pylori activities of six Iranian plants. Helicobacter, 9(2), 146-151. https://doi.org/10.1111/j.1083-4389.2004.00211.x
  • [43] Ndip, R. N., Tarkang, A. E. M., Mbullah, S. M., Luma, H. N., Malongue, A et al. (2007). In vitro anti-Helicobacter pylori activity of extracts of selected medicinal plants from North West Cameroon. J Ethnopharmacol. 114(3), 452-457. https://doi.org/10.1016/j.jep.2007.08.037
  • [44] Yan, J., Peng, C., Chen, P., Zhang, W., Jiang, C et al. (2022). In-vitro anti-Helicobacter pylori activity and preliminary mechanism of action of Canarium album Raeusch. fruit extracts. J Ethnopharmacol. 283, 114578. https://doi.org/10.1016/j.jep.2021.114578
  • [45] Gao, T., Hou, M., Zhang, B., Pan, X., Liu, C., Sun, C., ... & Ma, A. (2021). Effects of cranberry beverages on oxidative stress and gut microbiota in subjects with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial. Food Funct. 12(15), 6878-6888. https://doi.org/10.1039/D1FO00467K
  • [46] Chen, S., Shen, W., Liu, Y., Dong, Q., & Shi, Y. (2023). Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial. Chin Med J, 136(14), 1690-1698. https://mednexus.org/doi/epdf/10.1097/CM9.0000000000002696
  • [47] Edo, G. I., Obasohan, P., Makia, R. S., Abiola O, T., Umelo, E. C., Jikah, A. N., Umar, H. (2024). The use of quality control parameters in the evaluation of herbal drugs. A review. Discover Medicine, 1(1), 168. http://doi.org/10.1007/s44337-024-00177-6
  • [48] Wang, H., Chen, Y., Wang, L., Liu, Q., Yang, S., & Wang, C. (2023). Advancing herbal medicine: enhancing product quality and safety through robust quality control practices. Front Pharmacol, 14, 1265178. http://doi.org/10.3389/fphar.2023.1265178
There are 48 citations in total.

Details

Primary Language English
Subjects Bacteriology
Journal Section Review
Authors

Selin Sipahi Kuloğlu 0000-0001-9560-0225

Tuğçe Kalefetoğlu Macar 0000-0002-9946-8054

Oksal Macar 0000-0002-5067-8712

Submission Date October 8, 2025
Acceptance Date December 15, 2025
Publication Date December 24, 2025
Published in Issue Year 2025 Volume: 9 Issue: 2

Cite

APA Sipahi Kuloğlu, S., Kalefetoğlu Macar, T., & Macar, O. (2025). The Power of Herbal Extracts and Essential Oils in the Fight Against Helicobacter pylori: A Current Review. Aksaray University Journal of Science and Engineering, 9(2), 84-94. https://doi.org/10.29002/asujse.1799861

Aksaray J. Sci. Eng. | e-ISSN: 2587-1277 | Period: Biannually | Founded: 2017 | Publisher: Aksaray University | https://asujse.aksaray.edu.tr



ASUJSE is indexing&Archiving in

crossref-logo-landscape-100.png    scholar_logo_30dp.png          oaliblogo2.jpg   GettyImages_90309427_montage_255x130px.png search-result-logo-horizontal-TEST.jpg

22644 EBSCO


Creative Commons License